Does placental VEGF-A protein expression predict early neurological outcome of neonates from FGR complicated pregnancies?

• Published in: Journal of perinatal medicine Vol. 52; no. 7; pp. 783 - 792
• Main Authors: Grah, Maja, Poljak, Ljiljana, Starčević, Mirta, Stanojević, Milan, Vukojević, Katarina, Saraga-Babić, Mirna, Salihagić, Aida Kadić
• Format: Journal Article
• Language: English
• Published: Germany De Gruyter 25.09.2024
• Subjects: Adult; Case-Control Studies; early neurological outcome; Female; fetal growth restriction; Fetal Growth Retardation - metabolism; Humans; Infant, Newborn; placenta; Placenta - metabolism; Pregnancy; Vascular Endothelial Growth Factor A - metabolism; VEGF-A protein expression; early neurological outcome; placenta; VEGF-A protein expression; fetal growth restriction
• ISSN: 0300-5577; 1619-3997; 1619-3997
• DOI: 10.1515/jpm-2024-0138

Fetal hypoxia due to placental dysfunction is the hallmark of fetal growth restriction (FGR). Preferential perfusion of the brain (brain-sparing effect), as a part of physiological placental cardiovascular compensatory mechanisms to hypoxia, in FGR was reported. Therefore, the correlation between vascular endothelial growth factor A (VEGF-A) protein expression in the FGR placentas and newborns' early neurological outcome was examined. This study included 50 women with FGR complicated pregnancies and 30 uneventful pregnancies. Fetal hemodynamic parameters, neonatal acid-base status after delivery, placental pathohistology and VEGF-A expression were followed. Early neonatal morphological brain evaluation by ultrasound and functional evaluation of neurological status by Amiel - Tison Neurological Assessment at Term (ATNAT) were performed. VEGF-A protein expression level was significantly higher in the FGR placentas than normal term placentas (Fisher-Freeman-Halton's test, p≤0.001). No statistically significant correlation between placental VEGF-A expression and different prenatal and postnatal parameters was noticed. Whereas the alteration of an early neurological status assessed by ATNAT was found in 58 % of FGR newborns, morphological brain changes evaluated by UZV was noticed in 48 % of cases. No association between the level of placental VEGF-A expression and the early neurological deficits was found. As far as we know this is the first study of a possible connection between VEGF-A protein expression in the FGR placentas and neonates' early neurological outcomes. The lack of correlation between the FGR placental VEGF-A expression and neonates' neurological outcome could indicate that optimal early neurodevelopment may take place due to compensatory mechanism not related to placental VEGF-A expression.